Imishanguzo Yesikhathi Esidala Imithi KaPasinson
Ukuphathwa kwesifo sikaParkinson akusikho ubunzima bayo. Imithi ye-levodopa / carbidopa (eyaziwa nangokuthi iSinemet) isabhekwa njengokwelashwa okujwayelekile kwegolide yezimpawu zalesi sifo. Kodwa unikezwe iqiniso lokuthi iSinemet isenzo esifushane, kunezikhathi phakathi kwamanani lapho izimpawu zibuyela khona njengoba amazinga ezidakamizwa ehla. Futhi njengoba lesi sifo siphuthuka, le mithi ingasebenzi kahle ekulawuleni izimpawu zokuthuthuka.
Iziguli zidinga ukuthatha isilinganiso esiningi sokuzama ukuzama ukugwema "izinkathi zokuvala" lapho umphumela wezidakamizwa uvala khona.
Indlela ezuzisayo eyengeziwe ingaba ukwakheka okukhishwa i-levodopa / carbidopa kancane kancane, kunika amazinga amancane omuthi futhi kunciphise ukushintsha kwezimpawu. Lokhu kuzosho ukuthi "isikhathi esingaphansi" sesiguli seziguli zikaParkinson.
Indlela Esebenza ngayo
I-Rytary ivunyelwe ekwelapheni kwesifo sikaParkinson. Kuyindlela ejwayelekile yokukhululwa komlomo we-carbidopa / levodopa, inhlanganisela yezidakamizwa esetshenziselwe amashumi eminyaka efomini layo lokukhululwa ngokushesha (eyaziwa ngokujwayelekile ngegama lomkhiqizo, iSinemet). Ngokungafani ne-predetermined yayo, nge-Rytary, amazinga asheshayo futhi anwetshiwe we-carbidopa / levodopa atholakala egazini ngemuva kwesilinganiso esisodwa.
Ukwamukelwa kwalesi sidakamizwa kwavela imiphumela yemilingo emibili emitholampilo emikhulu. Okokuqala, i-APEX-PD kwakuyinkambo eyenzelwe kahle (okulawulwe ngamakhemikhali, ama-double blinded), lapho iziguli ezingu-381 ezinezifo zakuqala ze-Parkinson zithola khona ukulinganisa okukodwa kwezi ezintathu zomuthi noma i-placebo ngamasonto angu-30.
Imiphumela yabonisa ukuthuthukiswa kokubili amakhono emoto, umsebenzi wokuphila kwansuku zonke kanye nekhwalithi yokuphela kokuphila.
Ehluke ekutadisheni kokuqala, isilingo sesibili somtholampilo, i-ADVANCE-PD yabhalisa izifo ezinezifo ezithuthukile eziye zabhekana nokushintshashintsha kwezimoto noma "isikhathi sokuphumula." Iziguli ezingu-393 zazingenakulinganiswa ukuthola i-Rytary noma i-carbidopa-levodopa, ngokushesha.
Labo abathola imishanguzo emisha babe "kancane isikhathi", "okuholela ekutheni" ngesikhathi "ngaphandle kwama-dyskinesias uma kuqhathaniswa nalabo abathola imithi yabo evamile yokukhululwa ngokushesha.
Yini eyenza i-Rytary ibe ngcono?
I-Rytary akuyona ukulungiswa kokuqala okukhululwa. I-Stalevo (equkethe i-levodopa, i-carbidopa, ne-entacapone) iye yasemakethe kusukela futhi iphumelela ngempela ezigulini eziningi. Yini eyenza lokhu kukhishwa okusha kube ngcono?
"Ukugunyazwa kwe-FDA ye-RYTARY (i-rye-TAR-ee) ebizwa ngokuthi i-rye-TAR-ee) iyindlela entsha ebalulekile yokwelashwa kwesifo sikaParkinson futhi inikeza umkhiqizo we-carbidopa-levodopa owedlula isikhathi ophethe isifo sikaParkinson," kusho uFred Wilkinson, umongameli kanye ne-CEO, Impax. Ama-Laboratories. "I-RYTARY iklanyelwe ukubhekana nesidingo esisodwa esibaluleke kunazo zonke zeziguli eziphila nesifo sikaParkinson, okuzokwehlisa isikhathi esithile lapho usuku lwezimpawu zabo zingalawulwa ngokwanele."
Nakuba kungewona ukwelashwa esikulindele, i-Rytary inikeza esinye isidakamizwa ebhokisini lamathuluzi ekliniki. Udokotela wakho uzokwazi ukucacisa ukuthi noma akufanele yini ukuyisebenzisa ekuphathweni kwesifo sakho noma ngabe omunye umuthi uzonikeza imiphumela engcono.
Imithombo:
U-Beck, uJames, MD. "Ividiyo: I-FDA ivumela i-RYTARY &." Ividiyo: I-FDA ivumela i-RYTARY & . I-Parkinson's Disease Foundation, ngo-08 Jan. 2015. Iwebhu.
"I-Impax Pharmaceuticals Yemezela Ukugunyazwa kwe-FDA ka-RYTARY ™ (i-Carbidopa ne-Levodopa) Amaphakheji Akhulisiwe-Ukukhululwa Kwezifo ZasePasinson." I-Impax Pharmaceuticals Yemezela Ukuvunyelwa kwe-FDA ye-RYTARY ™ (i-Carbidopa ne-Levodopa) Amaphakheji Okukhuliswa Okukhulisiwe ... Impax Laboratories Inc., 08 Jan. 2015. Iwebhu.